AtriCure, Inc. (ATRC)
AtriCure makes surgical devices for treating atrial fibrillation and managing pain after surgery, sold mainly to medical centers. It last closed at $55.02 on Nov 17, down 0.52% on the day. ATRC last reported earnings on Thu, Jul 23, 2026. The average 12-month price target from 7 analysts is $66.29 (+20.5% from the last close), with a high of $70.00 and a low of $57.00. Analyst consensus is Buy, based on the latest ratings from 7 firms (5 buy, 2 hold, 0 sell). In the past 30 days there were 3 dark pool prints totaling $3.0M, the largest $1.6M.
Key Stats
Last 12 monthsNot reported for this period.
From ATRC's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 7 analysts who set a price target on ATRC in the past 90 days. The average target is $66.29, with a high of $70.00 and a low of $57.00, compared with the last close of $55.02.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 4 | Canaccord Genuity | Maintained | Buy | $67 |
| Nov 4 | JP Morgan | Maintained | Hold | $62 |
| Nov 4 | Piper Sandler | Target raised | Buy | $60 → $70 |
| Nov 4 | Needham | Target raised | Buy | $64 → $70 |
| Nov 4 | BTIG | Target raised | Buy | $55 → $70 |
Technical Analysis
The stock is 8% below its 20 day and 5% below its 50 day average. It is 29% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 43). The nearest support is the Pivot at $54.96, and the nearest resistance the swing high (Sep 8) at $55.72.
| RSI (14) | 42.50 | Middle of its range | Neutral |
| MACD | -0.32 | Below its signal line | Bearish |
| Stochastic | 11.0 | Near the bottom of its range | Oversold |
| ADX (14) | 20.7 | Weak trend | |
| Williams %R | -90.6 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -138.2 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −8.9% | Change over 10 sessions | Bearish |
| ATR (14) | $2.59 | Typical daily range, 4.7% of price |
| RSI (14) | 63.97 | Strong, overbought above 70 | Neutral |
| MACD | 6.16 | Above its signal line | Bullish |
| Stochastic | 62.7 | Middle of its range | Neutral |
| ADX (14) | 43.0 | Strong uptrend | |
| Williams %R | -48.6 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 45.4 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +0.9% | Change over 10 sessions | Bullish |
| ATR (14) | $4.38 | Typical daily range, 8.0% of price |
What happened before
See how ATRC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ATRC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in ATRC in the last 90 days.
Dark Pool
30DATRC Institutional Ownership
Full report →- ▲163 buying vs 136 selling
- ▲Held by funds +1.9 pts
- ▲Funds holding +34
- ●Superinvestors: 2 added, 2 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 286 | 252 | +13.5% |
| In funds' top 10 | 1 | 2 | −50.0% |
| Held by funds | 105.7% | 103.8% | +1.9 pts |
| New / increased | 80 / 83 | 50 / 100 | +8.7% |
| Reduced / sold out | 89 / 47 | 61 / 23 | +61.9% |
| Put/call ratio | – | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ATRC is in one of them and how their past ATRC trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ATRC in an article yet. Here's the latest on the wider market.
ATRC Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Gilbert CisnerosD · CA | Sell (partial) | $1K – $15K | Sep 29, 2026 | Oct 12, 2026 | 13 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Aug 20, 2026 | Sep 11, 2026 | 22 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Mar 3, 2026 | Apr 7, 2026 | 35 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | May 6, 2025 | Jun 6, 2025 | 31 d |
| Josh GottheimerD · NJ | Buy | $1K – $15K | Jul 19, 2024 | Aug 15, 2024 | 27 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About AtriCure
AtriCure makes surgical devices for treating atrial fibrillation, an irregular heartbeat, and for managing pain after surgery. Its ablation and left atrial appendage products, including the AtriClip system and the EPi-Sense ablation system, are used by surgeons and electrophysiologists during heart surgery and minimally invasive procedures. The company also sells cryo probes that freeze nerves to provide temporary relief from pain after cardiac, thoracic and amputation surgery. Its products are sold to medical centers through a direct sales force and distributors, and the company is based in Mason, Ohio.
- Headquarters
- Mason, OH
- Founded
- 2000
- Website
- atricure.com ↗





